Logo image
Tissue Fibrosis after Radiation Treatment for Breast Cancer
Book chapter

Tissue Fibrosis after Radiation Treatment for Breast Cancer

Kristin A. Plichta, Wenqing Sun and John M. Buatti
Toxicities of Radiation Treatment for Breast Cancer, pp.159-174
Springer International Publishing
03/16/2019
DOI: 10.1007/978-3-030-11620-0_9

View Online

Abstract

Radiation-induced fibrosis (RIF) is a late side effect from radiation therapy, occurring 4–12 months after radiation therapy, and can be seen in approximately 5–30% of patients receiving radiation therapy to the breast or chest wall. Typical effects of RIF include decreased tissue compliance, atrophy, skin retraction, and induration. Factors influencing the development of RIF include radiation dose, volume, radiation treatment technique, surgical complications, and the use of chemotherapy. Patient-related factors such as age, breast size, genetic background, and expression of molecular markers during radiation therapy are also associated with the development of RIF. Radiation-induced fibrosis may be partially reversible, and treatment strategies to potentially ameliorate the effects of RIF include physical therapy, medical management, and surgery. However, many of these techniques are preliminary, and further research is necessary before widespread clinical adoption.
Breast fibrosis Pentoxifylline Radiation-induced fibrosis Tissue compliance meter Vitamin E

Details

Metrics

50 Record Views
Logo image